Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04677387 · ClinicalTrials.gov registry record · NA
Nalox-Comm: Naloxone Communication Training for Pharmacists
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT04677387 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 48 participants.
The verdict
NCT04677387, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
This is a pilot Randomized Controlled Trial (RCT) in which 120 pharmacists will be randomized to an experimental or control group and data on naloxone dispensing and secondary outcomes will be collected over the course of the RCT.
Interventions
- BEHAVIORAL Nalox-comm Training Module
- BEHAVIORAL Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2023-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04677387
The ClinicalTrials.gov registry entry for NCT04677387 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nalox-comm Training Module is the first listed.
NCT04677387 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04677387 about?
NCT04677387 is a clinical study titled "Nalox-Comm: Naloxone Communication Training for Pharmacists". This is a pilot Randomized Controlled Trial (RCT) in which 120 pharmacists will be randomized to an experimental or control group and data on naloxone dispensing and secondary outcomes will be collected over the course of the RCT.
What is the current status of trial NCT04677387?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2021-07-01. Estimated completion is 2023-07-31.
What interventions are being tested in trial NCT04677387?
The interventions under investigation include: Nalox-comm Training Module (BEHAVIORAL), Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists (BEHAVIORAL).
Who is sponsoring clinical trial NCT04677387?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.